Control of mitochondrial functions by Pseudomonas aeruginosa in cystic fibrosis
International Review of Cell and Molecular Biology · 2023
DOI: 10.1016/bs.ircmb.2023.03.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Review of Cell and Molecular Biology, 2023. Verfasst von Giulia Pellielo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Section of Experimental Medicine, Laboratory for Technologies of Advanced Therapies, University of Ferrara, Ferrara, …. Hauptthemen laut MEDLINE: Cystic Fibrosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 127 Literaturangaben. Gefördert von: Ministero della Salute, Ministero dell’Istruzione, dell’Università e della Ricerca, Associazione Italiana per la Ricerca sul Cancro.
Abstract (Originalsprache)
Cystic fibrosis (CF) is a genetic disease characterized by mutations of cystic fibrosis transmembrane conductance regulator (CFTR) gene, which lead to a dysfunctional chloride and bicarbonate channel. Abnormal mucus viscosity, persistent infections and hyperinflammation that preferentially affect the airways, referred to the pathogenesis of CF lung disease. It has largely demonstrated that Pseudomonas aeruginosa (P. aeruginosa) represents the most important pathogen that affect CF patients, leading to worsen inflammation by stimulating pro-inflammatory mediators release and tissue destruction. The conversion to mucoid phenotype and formation of biofilms, together with the increased frequency of mutations, are only few changes that characterize the P. aeruginosa's evolution during CF lung chronic infection. Recently, mitochondria received increasing attention due to their involvement in inflammatory-related diseases, including in CF. Alteration of mitochondrial homeostasis is sufficient to stimulate immune response. Exogenous or endogenous stimuli that perturb mitochondrial activity are used by cells, which, through the mitochondrial stress, potentiate immunity programs. Studies show the relationship between mitochondria and CF, supporting the idea that mitochondrial dysfunction endorses the exacerbation of inflammatory responses in CF lung. In particular, evidences suggest that mitochondria in CF airway cells are more susceptible to P. aeruginosa infection, with consequent detrimental effects that lead to amplify the inflammatory signals. This review discusses the evolution of P. aeruginosa in relationship with the pathogenesis of CF, a fundamental step to establish chronic infection in CF lung disease. Specifically, we focus on the role of P. aeruginosa in the exacerbation of inflammatory response, by triggering mitochondria in CF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Sciences, Section of Experimental Medicine, Laboratory for Technologies of Advanced Therapies, University of Ferrara, Ferrara, Italy.
- Department of Medical Sciences, Section of Experimental Medicine, Laboratory for Technologies of Advanced Therapies, University of Ferrara, Ferrara, Italy; Center of research for innovative therapies in cystic fibrosis,…
Förderung
- Ministero della Salute
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Associazione Italiana per la Ricerca sul Cancro
- Università degli Studi di Ferrara
Zitieren
APA
Pellielo, G., Agyapong, E. D., Pinton, P., & Rimessi, A. (2023). Control of mitochondrial functions by Pseudomonas aeruginosa in cystic fibrosis. International Review of Cell and Molecular Biology. https://doi.org/10.1016/bs.ircmb.2023.03.008
Vancouver
Pellielo G, Agyapong ED, Pinton P, Rimessi A. Control of mitochondrial functions by Pseudomonas aeruginosa in cystic fibrosis. International Review of Cell and Molecular Biology. 2023. doi:10.1016/bs.ircmb.2023.03.008
BibTeX
@article{Pellielo2023,
author = {Pellielo, Giulia and Agyapong, Esther Densu and Pinton, Paolo and Rimessi, Alessandro},
title = {Control of mitochondrial functions by Pseudomonas aeruginosa in cystic fibrosis},
journal = {International Review of Cell and Molecular Biology},
year = {2023},
doi = {10.1016/bs.ircmb.2023.03.008}
}
EUVIMED